If you're working in community pharmacy, you may get some questions about this during the week.
A study has found that a new drug has the potential to slow down and even modify the progression of Alzheimer's disease.
It's the first time a drug has been found to have the potential to actually slow down, not just treat the symptoms of the disease which affects more than 360,000 Canadians.
Alzheimer's impairs memory and basic abilities, and leads to irreversible brain cell loss.
The new drug, Flurizan, is not on the general market yet, but was studied in patients who are experiencing mild to moderate stages of the disease...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment